The Chemours Company (NYSE:CC) Delivered A Better ROE Than Its Industry [Yahoo! Finance]
Chemours Company (The) (CC)
Last chemours company (the) earnings: 2/13 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.chemours.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
To keep the lesson grounded in practicality, we'll use ROE to better understand The Chemours Company ( NYSE:CC ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. ROE can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Chemours is: 14% = US$86m ÷ US$605m (Based on the trailing twelve months to December 2024). The 'return' is the yearly profit. Another way to think of that is that for every $1 worth of equity, the company was
Show less
Read more
Impact Snapshot
Event Time:
CC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CC alerts
High impacting Chemours Company (The) news events
Weekly update
A roundup of the hottest topics
CC
News
- Fluoroelastomers (FKM) Market Size to Reach a Valuation of USD 2.79 Billion by 2033; High Demand for FKM from Automotive Industry to Augment Market Expansion [Yahoo! Finance]Yahoo! Finance
- Chemours Company (CC) Up More than 12% Since Q3, Here's What Wall Street Thinks About the Stock [Yahoo! Finance]Yahoo! Finance
- JPMorgan Reduces PT on The Chemours Company (CC) to $13 From $15, Keeps a Neutral Rating [Yahoo! Finance]Yahoo! Finance
- Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián GumpelBusiness Wire
- Chemours (NYSE:CC) had its price target lowered by analysts at JPMorgan Chase & Co. from $15.00 to $13.00. They now have a "neutral" rating on the stock.MarketBeat
CC
Earnings
- 11/6/25 - Beat
CC
Sec Filings
- 11/6/25 - Form 10-Q
- 11/6/25 - Form 8-K
- 10/31/25 - Form 8-K
- CC's page on the SEC website